4.8 Article

Intrabilayer 64Cu Labeling of Photoactivatable, Doxorubicin-Loaded Stealth Liposomes

期刊

ACS NANO
卷 11, 期 12, 页码 12482-12491

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.7b06578

关键词

liposomes; porphyrin-phospholipid; doxorubicin; image-guided drug delivery; chemophototherapy

资金

  1. National Institutes of Health [R01EB017270, DP50D017898, 1R01CA169365, P30CA014520, ULITR001412]
  2. National Science Foundation [1555220]
  3. University of Wisconsin Madison
  4. American Cancer Society [125246-RSG-13-099-01-CCE]
  5. National Natural Science Foundation of China [81572998, 81773274]
  6. Direct For Mathematical & Physical Scien
  7. Division Of Materials Research [1555220] Funding Source: National Science Foundation

向作者/读者索取更多资源

Doxorubicin (Dox)-loaded stealth liposomes (similar to those in clinical use) can incorporate small amounts of porphyrin-phospholipid (PoP) to enable chemophototherapy (CPT). PoP is also an intrinsic and Ex), intrabilayer Cu-64 chelator, although how radiolabeling impacts drug delivery has not yet been assessed. Here, we show that Cu-64 can radiolabel the stable bilayer of preformed Dox-loaded PoP liposomes with inclusion of 1% ethanol without inducing drug leakage. Dox-PoP liposomes labeled with intrabilayer copper behaved nearly identically to unlabeled ones in vitro and in vivo with respect to physical parameters, pharmacokinetics, and CPT efficacy. Positron emission tomography and near-infrared fluorescence imaging visualized orthotopic mammary tumors in mice with passive liposome accumulation following administration. A single CPT treatment with 665 sun light (200 J/cm(2)) strongly inhibited primary tumor growth. Liposomes accumulated in lung metastases, based on MR imaging. These. results establish the feasibility of CPT interventions guided by intrinsic multimodal imaging of Dox-loaded stealth PoP liposomes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据